Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

Early Investigator Awards

Overview: Lynn Sage Scholar research grants that support early-career researchers launching bold new ideas in breast cancer research.

Focus Areas:

  • Breast cancer detection and treatment improvements

  • Triple negative breast cancer (TNBC)

  • Tumor extracellular vesicles and immune regulation

  • Artificial intelligence applications in breast cancer

  • Immunotherapy and personalized medicine

  • Breast cancer biomarkers and diagnostics
  • Geographic Scope: Chicago-area based researchers, though investments drive impact globally

    Eligibility: Early-career researchers at academic institutions

    Current & Past Investigators Include:

  • Dr. Lamiaa El-Shennawy, Northwestern University Feinberg School of Medicine

  • Dr. Frederick Howard, University of Chicago

  • Jeffrey Schneider, PhD, Rush University Medical Center

  • Dr. Nurmaa K. Dashzeveg (2024-25)

  • Dr. Nan Chen (2024-25)

  • Dr. Peiwen Chen (2022-23)

  • Dr. Arjun Raman (2022-23)

  • Dr. Lu Wang (2022-23)

  • Dr. Zhe Ji (2020-22)

  • Elizabeth Hibler, PhD (2020-22)
  • Organization: Lynn Sage Breast Cancer Foundation

    Contact:

  • Phone: 312.252.2502

  • Email: info@lynnsage.org

  • Address: 3023 N. Clark Street Suite 139, Chicago, IL 60657
  • Background: Lynn Sage was an early investor in the study of Tamoxifen, which is now the standard of care treatment for hormone-receptor-positive breast cancer. 94% of funds raised go to research & education.

    Focus Areas & Funding Uses

    Fields of Work

    cancerscience-research

    Categories

    Browse similar grants by category

    Related Grants

    Similar grants from this funder and related organizations

    Ready to apply for Early Investigator Awards?

    Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.